Pay in 4 interest-free payments of $6.93 Learn more
Ships within 48 hours · Estimated delivery Aug 29 - Sep 3
The following features would enhance the value of an obesity therapeutic, but would likely be assessed in follow-up trials or even post-approval: Additional efficacy in obesity-related co-morbidities
JYM L-Carnitine supports the cellular machinery that helps fatty acids get converted into usable fuelwithout relying on stimulants
Recalls & Warnings May 10, 2013 Maker of Concentration, Pain, Immune, Cholesterol Supplements Warned For Drug Claims On April 24, 2013, the FDA issued a warning letter to EuroPharma Co., Inc., following a review of the company's website which found statements made about Calm Kids, CholestCaps, CuraMed 375 mg, CuraMed 750 mg, Curamin, Mental Advantage, Tri-Iodine, and Viragen to be drug claims
Another drug with a similar mechanism of action (setmelanotide) is approved for weight loss in rare types of obesity
US$ 21.75
US$ 28.72
US$ 24.60
US$ 26.66
US$ 24.59
